. 2019 Feb;20(2).
doi: 10.1016/S1470-2045(18)30952-5.

Modulating the microbiome to improve therapeutic response in cancer

Jennifer L McQuade 1 Carrie R Daniel 2 Beth A Helmink 3 Jennifer A Wargo 4 
  • PMID: 30712808
  •     45 citations


Although novel therapies, including immunotherapy, have dramatically improved outcomes for many patients with cancer, overall outcomes are heterogeneous and existing biomarkers do not reliably predict response. To date, predictors of response to cancer therapy have largely focused on tumour-intrinsic features; however, there is growing evidence that other host factors (eg, host genomics and the microbiome) can substantially affect therapeutic response. The microbiome, which refers to microbiota within a host and their collective genomes, is becoming increasingly recognised for its influence on host immunity, as well as therapeutic responses to cancer treatment. Importantly, microbiota can be modified via several different strategies, affording new angles in cancer treatment to improve outcomes. In this Review, we examine the evidence on the role of the microbiome in cancer and therapeutic response, factors that influence and shape host microbiota, strategies to modulate the microbiome, and present key unanswered questions to be addressed in ongoing and future research.

Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls.
Travis T Sims, Lauren E Colbert, +8 authors, Ann Klopp.
Gynecol Oncol, 2019 Sep 11; 155(2). PMID: 31500892    Free PMC article.
Immune Checkpoints as Promising Targets for the Treatment of Idiopathic Pulmonary Fibrosis?
JanWillem Duitman, Tom van den Ende, C Arnold Spek.
J Clin Med, 2019 Sep 29; 8(10). PMID: 31561518    Free PMC article.
Impact of the microbiome on checkpoint inhibitor treatment in patients with non-small cell lung cancer and melanoma.
Fyza Y Shaikh, Joell J Gills, Cynthia L Sears.
EBioMedicine, 2019 Oct 11; 48. PMID: 31597596    Free PMC article.
Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.
Ziying Zhang, Haosheng Tang, +2 authors, Yongguang Tao.
Signal Transduct Target Ther, 2019 Oct 23; 4. PMID: 31637019    Free PMC article.
Temperature as a modulator of the gut microbiome: what are the implications and opportunities for thermal medicine?
Bonnie L Hylander, Elizabeth A Repasky.
Int J Hyperthermia, 2019 Dec 05; 36(sup1). PMID: 31795833    Free PMC article.
Melanoma-Bearing Libechov Minipig (MeLiM): The Unique Swine Model of Hereditary Metastatic Melanoma.
Vratislav Horak, Anna Palanova, +3 authors, Helena Kupcova Skalnikova.
Genes (Basel), 2019 Nov 14; 10(11). PMID: 31717496    Free PMC article.
Gut Bacteria and their Metabolites: Which One Is the Defendant for Colorectal Cancer?
Samira Tarashi, Seyed Davar Siadat, +4 authors, Arfa Moshiri.
Microorganisms, 2019 Nov 27; 7(11). PMID: 31766208    Free PMC article.
microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance.
Wen Cai Zhang.
Int J Mol Sci, 2019 Dec 11; 20(23). PMID: 31816897    Free PMC article.
Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.
Wanxin Liu, Ren Zhang, +15 authors, Qingming Wu.
Biomed Res Int, 2020 Feb 23; 2020. PMID: 32083132    Free PMC article.
Gut Microbiome Modulates Response to Cancer Immunotherapy.
Md Abdul Wadud Khan, Gabriel Ologun, +2 authors, Jennifer A Wargo.
Dig Dis Sci, 2020 Feb 19; 65(3). PMID: 32067144    Free PMC article.
Mechanisms and Implications of Metabolic Heterogeneity in Cancer.
Jiyeon Kim, Ralph J DeBerardinis.
Cell Metab, 2019 Sep 05; 30(3). PMID: 31484055    Free PMC article.
Mitogen-Activated Protein Kinase (MAPK) and Obesity-Related Cancer.
Fionán Donohoe, Michael Wilkinson, Eva Baxter, Donal J Brennan.
Int J Mol Sci, 2020 Feb 20; 21(4). PMID: 32069845    Free PMC article.
DeepMicro: deep representation learning for disease prediction based on microbiome data.
Min Oh, Liqing Zhang.
Sci Rep, 2020 Apr 09; 10(1). PMID: 32265477    Free PMC article.
Interplay between Dietary Polyphenols and Oral and Gut Microbiota in the Development of Colorectal Cancer.
Carolina Cueva, Mariana Silva, +2 authors, M Victoria Moreno-Arribas.
Nutrients, 2020 Mar 04; 12(3). PMID: 32120799    Free PMC article.
HIV, Cancer, and the Microbiota: Common Pathways Influencing Different Diseases.
Sabina Herrera, Javier Martínez-Sanz, Sergio Serrano-Villar.
Front Immunol, 2019 Jul 19; 10. PMID: 31316514    Free PMC article.
Fecal Microbial Transplantation for Diseases Beyond Recurrent Clostridium Difficile Infection.
Geert R D'Haens, Christian Jobin.
Gastroenterology, 2019 Jun 21; 157(3). PMID: 31220424    Free PMC article.
The cancer microbiome.
Eran Elinav, Wendy S Garrett, Giorgio Trinchieri, Jennifer Wargo.
Nat Rev Cancer, 2019 Jun 13; 19(7). PMID: 31186547    Free PMC article.
Highly Cited. Review.
A review of cancer immunotherapy: from the past, to the present, to the future.
K Esfahani, L Roudaia, +3 authors, W H Miller.
Curr Oncol, 2020 May 06; 27(Suppl 2). PMID: 32368178    Free PMC article.
Modifiable Host Factors in Melanoma: Emerging Evidence for Obesity, Diet, Exercise, and the Microbiome.
Allison Betof Warner, Jennifer L McQuade.
Curr Oncol Rep, 2019 Jul 03; 21(8). PMID: 31263961    Free PMC article.
The future of cancer immunotherapy: microenvironment-targeting combinations.
Yonina R Murciano-Goroff, Allison Betof Warner, Jedd D Wolchok.
Cell Res, 2020 May 30; 30(6). PMID: 32467593    Free PMC article.
Variations of Gut Microbiome Profile Under Different Storage Conditions and Preservation Periods: A Multi-Dimensional Evaluation.
Junli Ma, Lili Sheng, +14 authors, Houkai Li.
Front Microbiol, 2020 Jun 17; 11. PMID: 32536906    Free PMC article.
Immunotherapy in Colorectal Cancer: Potential of Fecal Transplant and Microbiota-augmented Clinical Trials.
Robin Park, Shahid Umar, Anup Kasi.
Curr Colorectal Cancer Rep, 2020 Jul 02; 16(4). PMID: 32607098    Free PMC article.
Integrating the Tumor Microenvironment into Cancer Therapy.
Sabina Sanegre, Federico Lucantoni, +3 authors, Tomás Álvaro Naranjo.
Cancers (Basel), 2020 Jul 01; 12(6). PMID: 32599891    Free PMC article.
Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer.
Byung Woog Kang, Ian Chau.
ESMO Open, 2020 Aug 21; 5(4). PMID: 32817133    Free PMC article.
Diversity of Gut Microbiota and Bifidobacterial Community of Chinese Subjects of Different Ages and from Different Regions.
Bo Yang, Shuang Yan, +5 authors, Wei Chen.
Microorganisms, 2020 Jul 30; 8(8). PMID: 32722057    Free PMC article.
Clinicopathological Features, Staging, and Current Approaches to Treatment in High-Risk Resectable Melanoma.
Emily Z Keung, Jeffrey E Gershenwald.
J Natl Cancer Inst, 2020 Feb 16; 112(9). PMID: 32061122    Free PMC article.
Fecal Microbiome Alteration May Be a Potential Marker for Gastric Cancer.
Juan Wu, Cong Zhang, +9 authors, Junfeng Zhang.
Dis Markers, 2020 Oct 06; 2020. PMID: 33014185    Free PMC article.
Gut microbiota regulate tumor metastasis via circRNA/miRNA networks.
Zhuxian Zhu, Jianguo Huang, +9 authors, Ziqiang Zhang.
Gut Microbes, 2020 Jul 21; 12(1). PMID: 32686598    Free PMC article.
Emerging role of bacterial extracellular vesicles in cancer.
Antonios Chronopoulos, Raghu Kalluri.
Oncogene, 2020 Oct 17; 39(46). PMID: 33060855    Free PMC article.
Boosting the Immune Response with the Combination of Electrochemotherapy and Immunotherapy: A New Weapon for Squamous Cell Carcinoma of the Head and Neck?
Francesco Longo, Francesco Perri, +8 authors, Raffaele Solla.
Cancers (Basel), 2020 Oct 02; 12(10). PMID: 32998297    Free PMC article.
The Use of Immune Checkpoint Inhibitors in Oncology and the Occurrence of AKI: Where Do We Stand?
Rossana Franzin, Giuseppe Stefano Netti, +5 authors, Elena Ranieri.
Front Immunol, 2020 Nov 10; 11. PMID: 33162990    Free PMC article.
Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy.
Agnieszka Beata Malczewski, Severine Navarro, Jermaine Ig Coward, Natkunam Ketheesan.
J Immunother Cancer, 2020 Nov 01; 8(2). PMID: 33127655    Free PMC article.
Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers.
Jennifer L McQuade, Gabriel O Ologun, Reetakshi Arora, Jennifer A Wargo.
Curr Oncol Rep, 2020 Jun 25; 22(7). PMID: 32577835    Free PMC article.
Effects of Intestinal Microbial⁻Elaborated Butyrate on Oncogenic Signaling Pathways.
Jiezhong Chen, Kong-Nan Zhao, Luis Vitetta.
Nutrients, 2019 May 10; 11(5). PMID: 31067776    Free PMC article.
MASI: microbiota-active substance interactions database.
Xian Zeng, Xue Yang, +8 authors, Yu Zong Chen.
Nucleic Acids Res, 2020 Oct 31; 49(D1). PMID: 33125077    Free PMC article.
Uncovering the microbiota in renal cell carcinoma tissue using 16S rRNA gene sequencing.
Junpeng Wang, Xin Li, +5 authors, Tianzhong Yan.
J Cancer Res Clin Oncol, 2020 Nov 22; 147(2). PMID: 33219401
Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qin Qiu, Yuqi Lin, +8 authors, Lianxiang Luo.
Front Immunol, 2021 Jan 26; 11. PMID: 33488618    Free PMC article.
Heritable Gut Microbiome Associated with Salmonella enterica Serovar Pullorum Infection in Chickens.
Jinmei Ding, Hao Zhou, +14 authors, He Meng.
mSystems, 2021 Jan 07; 6(1). PMID: 33402350    Free PMC article.
Tumor-Associated Microbiome: Where Do We Stand?
Marc Oliva, Nuria Mulet-Margalef, +7 authors, Victor Moreno.
Int J Mol Sci, 2021 Feb 05; 22(3). PMID: 33535583    Free PMC article.
Can we harness the microbiota to enhance the efficacy of cancer immunotherapy?
B Brett Finlay, Romina Goldszmid, +3 authors, Laurence Zitvogel.
Nat Rev Immunol, 2020 Jul 15; 20(9). PMID: 32661409
Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Sama Rezasoltani, Abbas Yadegar, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali.
Cancer Med, 2020 Dec 29; 10(3). PMID: 33369247    Free PMC article.
Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical Cancer.
Aparna Mitra, Greyson Willis Grossman Biegert, +16 authors, Ann H Klopp.
Int J Radiat Oncol Biol Phys, 2020 Jan 29; 107(1). PMID: 31987960    Free PMC article.
Gut microbiome diversity is an independent predictor of survival in cervical cancer patients receiving chemoradiation.
Travis T Sims, Molly B El Alam, +21 authors, Ann H Klopp.
Commun Biol, 2021 Feb 24; 4(1). PMID: 33619320    Free PMC article.
Immune-Related Mutational Landscape and Gene Signatures: Prognostic Value and Therapeutic Impact for Head and Neck Cancer.
Bohai Feng, Jochen Hess.
Cancers (Basel), 2021 Apr 04; 13(5). PMID: 33800421    Free PMC article.
Thinking Small: Small Molecules as Potential Synergistic Adjuncts to Checkpoint Inhibition in Melanoma.
Alexander C Chacon, Alexa D Melucci, Shuyang S Qin, Peter A Prieto.
Int J Mol Sci, 2021 Apr 04; 22(6). PMID: 33810078    Free PMC article.